Top feature box IMAGE ONLY - COMPANY NEWS
 |
Press Releases
Cardinal Health CFO to Speak at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
02/08/2006
DUBLIN, Ohio, Feb. 7 /PRNewswire-FirstCall/ -- Cardinal Health Chief Financial Officer Jeffrey Henderson will address investors at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference in New York on Feb. 9, 2006 at 11:00 a.m. eastern standard time.
Mr. Henderson will discuss Cardinal Health's diverse products and services, company performance and strategies for continued growth. His remarks will be webcast live at http://www.wsw.com/webcast/ml53/cah/.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services. Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients. The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies. Ranked No. 16 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents. More information about the company may be found at http://www.cardinalhealth.com.
